CRED Getting the CMC Dossier Right 2024

05/09/2024

Learning Outcomes

• Issues faced at different phases of development

• Select the specific product type required

• ICH Q8 & Quality by Design

• Medicinal product production and scale up

• Process validation requirements for different dosage forms

• Stability programmes and data requirements

• When/how to deal with changes during development to ensure this does not invalidate clinical/other data already generated

The Organisation for Professionals in Regulatory Affairs

33

17